scholarly article | Q13442814 |
P2093 | author name string | HUNGERFORD DA | |
NOWELL PC | |||
P. C. NOWELL | |||
D. A. HUNGERFORD | |||
P407 | language of work or name | English | Q1860 |
P921 | main subject | chronic myeloid leukemia | Q729735 |
chromosome abnormality | Q744962 | ||
P304 | page(s) | 1013-1035 | |
P577 | publication date | 1961-11-01 | |
P1433 | published in | Journal of the National Cancer Institute | Q400279 |
P1476 | title | Chromosome studies in human leukemia. II. Chronic granulocytic leukemia | |
P478 | volume | 27 |
Q41582172 | A complex pattern of chromosome abnormalities in the acute phase of chronic granulocytic leukaemia. |
Q34744320 | A general theory of carcinogenesis |
Q41444680 | A new approach to the evolution of the blastic crisis from chronic myelocytic leukemia: dynamic interplay of cellular alterations and a changing microenvironment |
Q71058130 | A possible explanation for the origin of the Philadelphia chromosome |
Q36785029 | A review of resistance patterns and phenotypic changes in gastrointestinal stromal tumors following imatinib mesylate therapy |
Q41317103 | Action of chloroquine phosphate in rheumatoid arthritis. II. Chromosome damaging effect |
Q36344001 | Analysis of rat hemopoietic cells on the fluorescence-activated cell sorter. II. Isolation of terminal deoxynucleotidyl transferase-positive cells |
Q39919786 | Anomalies of the Small Acrocentric (chromosomes in Human Tumour Cells* |
Q70901424 | Autologous versus homologous culture media in blood cultures from patients with chronic myelogenous leukaemia. Comparison of the cytogenetic pictures |
Q76653547 | CHROMOSOME PREPARATIONS FROM THE INTESTINAL MUCOSA |
Q72025624 | Chemotherapy of autochthonous myeloid leukemias (Chloroleukemias) in Wistar rats |
Q36743640 | Chromosomal aberration frequency in lymphocytes predicts the risk of cancer: results from a pooled cohort study of 22 358 subjects in 11 countries |
Q70919166 | Chromosomal studies in chronic myeloic leukemia |
Q41517825 | Chromosome aberrations in leukocytes exposed in vitro to diagnostic levels of x-rays |
Q70862817 | Chromosome breakages in four chronic myeloid leukemia patients |
Q35935700 | Chromosome complement of lymph node cells in Hodgkin's disease |
Q36471739 | Chronic Myeloid Leukaemia: A paradigm for malignancy or just a strange disease? |
Q33386690 | Classification of lymphoid neoplasms: the microscope as a tool for disease discovery |
Q36449899 | Complex mitochondrial DNA in leukemic and normal human myeloid cells |
Q37698231 | Detection of BCR-ABL Positive Cells in an Asymptomatic Patient: A Case Report and Literature Review |
Q90644136 | Detection of Novel Fusion Transcript VTI1A-CFAP46 in Hepatocellular Carcinoma |
Q24683696 | Discovery of the Philadelphia chromosome: a personal perspective |
Q42072139 | Don't Mess with RUNX1. |
Q70920911 | Double Philadelphia chromosome and isochromosome 17 in the terminal phase of chronic myeloid leukemia |
Q92409425 | Epigenetic Reprogramming and Emerging Epigenetic Therapies in CML |
Q34532048 | Expression and activity of Fyn mediate proliferation and blastic features of chronic myelogenous leukemia |
Q35650512 | Genome-wide assessment of recurrent genomic imbalances in canine leukemia identifies evolutionarily conserved regions for subtype differentiation |
Q50098629 | How is the Ph-like signature being incorporated into ALL therapy? |
Q72622697 | Human peripheral blood in tissue culture and the action of phytohemagglutinin |
Q35982752 | Hypoxia-Like Signatures Induced by BCR-ABL Potentially Alter the Glutamine Uptake for Maintaining Oxidative Phosphorylation |
Q92363766 | Identification of key candidate targets and pathways for the targeted treatment of leukemia stem cells of chronic myelogenous leukemia using bioinformatics analysis |
Q40345637 | Interaction of the seed and the soil |
Q37110802 | Is it important to decipher the heterogeneity of "normal karyotype AML"? |
Q36383369 | Landscape of gene fusions in epithelial cancers: seq and ye shall find |
Q38185576 | Maintaining low BCR-ABL signaling output to restrict CML progression and enable persistence |
Q36461888 | Malignant conversion of cells in vitro by carcinogens and viruses |
Q28076328 | Modeling of Chronic Myeloid Leukemia: An Overview of In Vivo Murine and Human Xenograft Models |
Q49914671 | Modeling the human bone marrow niche in mice: From host bone marrow engraftment to bioengineering approaches |
Q35939340 | Multiple myeloma superimposed on chronic myelocytic leukemia |
Q41561881 | Pure red cell hypoplasia associated with long-arm deletion of chromosome 5 |
Q30276545 | Recurrent cis-SAGe chimeric RNA, D2HGDH-GAL3ST2, in prostate cancer |
Q37194503 | Recurrent gene fusions in prostate cancer |
Q26851525 | Recurrent rearrangements in prostate cancer: causes and therapeutic potential |
Q40002580 | Regulatory mechanisms acting on hemopoietic stem cells. Some clinical implications. |
Q42339101 | SOCS1 function in BCR-ABL mediated myeloproliferative disease is dependent on the cytokine environment |
Q36214189 | Sequencing Strategies to Guide Decision Making in Cancer Treatment. |
Q38926441 | Somatic Engineering of Oncogenic Chromosomal Rearrangements: A Perspective |
Q34523506 | Successful pregnancy in a patient with chronic myeloid leukaemia exposed to dasatinib during the first trimester |
Q30396342 | The Microscope as a Tool for Disease Discovery-A Personal Voyage |
Q34193206 | The new biomedical technology. |
Q39551053 | The non-coding oncogene: a case of missing DNA evidence? |
Q38097382 | The war on cancer: are we winning? |
Q41093037 | Transcriptome profiling identifies a recurrent CRYL1-IFT88 chimeric transcript in hepatocellular carcinoma |
Q36395595 | Transformation induced by simian virus 40 in human renal cell cultures. I. Morphology and growth characteristics |
Q35694365 | Translating cancer 'omics' to improved outcomes |
Q43248935 | Translational research: are we on the right track? 2008 American Society for Clinical Investigation Presidential Address |
Q37363960 | Translocations in epithelial cancers |
Q38734590 | Transposon-mediated generation of BCR-ABL1-expressing transgenic cell lines for unbiased sensitivity testing of tyrosine kinase inhibitors |
Q37806625 | Triggers for genomic rearrangements: insights into genomic, cellular and environmental influences |
Q93481901 | Trio receives Lasker Foundation Clinical Award for breakthroughs in leukemia treatment |
Q30480984 | Using Bcr-Abl to examine mechanisms by which abl kinase regulates morphogenesis in Drosophila. |
Q52759227 | Validation of a Targeted RNA Sequencing Assay for Kinase Fusion Detection in Solid Tumors. |
Q53829916 | [DNA (Feulgen) and chromosome studies in mongolism with acute leukemia]. |
Q54123354 | gDNA qPCR is statistically more reliable than mRNA analysis in detecting leukemic cells to monitor CML. |
Search more.